Finance

Lists
000623:SHE
Jilin Aodong Pharmaceutical Group Co Ltd
17,10 CNY
-0,29%
(-0,050) 1D
16 ოქტ, 15:04:09 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000623...
Open
17,22 CNY
High
17,38 CNY
Low
17,00 CNY
Mkt. cap
20,81 მლრდ.
Avg. vol.
9,08 მლნ.
Volume
10,80 მლნ.
P/E ratio
6,34
52-wk high
22,08 CNY
52-wk low
16,36 CNY
EPS
2,70 CNY
Shares outstanding
1,20 მლრდ.
No. of employees
5 ათ.
Open
17,22 CNY
High
17,38 CNY
Low
17,00 CNY
Mkt. cap
20,81 მლრდ.
Avg. vol.
9,08 მლნ.
Volume
10,80 მლნ.
P/E ratio
6,34
52-wk high
22,08 CNY
52-wk low
16,36 CNY
EPS
2,70 CNY
Shares outstanding
1,20 მლრდ.
No. of employees
5 ათ.
News stories
From web sources and news partners
The Daily News | Texas' Oldest Newspaper
The Daily News | Texas' Oldest Newspaper
·
14 წუთის წინ
FILE PHOTO: Traders work on the floor of the New York Stock Exchange (NYSE) in New York City
3D Printing Industry
3D Printing Industry
·
56 წუთის წინ
Amaero Nets $15.7M in Nasdaq IPO but Expects to Need More Capital in 2027
Opening Bell Daily
Opening Bell Daily
·
13 წუთის წინ
Stock Market Outlook: Stock pickers are lagging the index
Yahoo Finance
Yahoo Finance
·
1 საათის წინ
Buy 5 Top-Ranked Non-Tech Nasdaq Stocks to Maximize Q4 Gains
Profile
Jilin Aodong Medicine Industry Group Company Limited is a state-owned enterprise in Dunhua, Jilin, China. It involves in the manufacture and sale of Chinese patent drugs and pharmaceutical packaging products, and the collection of traffic tolls and the road engineering construction business. It was established in 1993 and listed on the Shenzhen Stock Exchange in 1996. Wikipedia
About Jilin Aodong Pharmaceutical Group Co Ltd
CEO-
Employees5,05 ათ.
Founded20 მარ. 1993
Headquarters-
SectorPharmaceutical industry
Websitejlaod.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
513,94 მლნ.
694,88 მლნ.
514,09 მლნ.
516,91 მლნ.
Cost of goods sold
277,23 მლნ.
401,66 მლნ.
265,19 მლნ.
285,23 მლნ.
Cost of revenue
277,23 მლნ.
401,66 მლნ.
265,19 მლნ.
285,23 მლნ.
Research and development expenses
20,32 მლნ.
50,31 მლნ.
14,36 მლნ.
14,41 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
217,18 მლნ.
375,32 მლნ.
194,13 მლნ.
204,97 მლნ.
Operating expense
213,20 მლნ.
462,78 მლნ.
225,97 მლნ.
230,21 მლნ.
Total operating expenses
490,43 მლნ.
864,44 მლნ.
491,16 მლნ.
515,45 მლნ.
Operating income
23,51 მლნ.
-169,57 მლნ.
22,94 მლნ.
1,46 მლნ.
Other non operating income
8,50 მლნ.
-11,31 მლნ.
-653,65 ათ.
1,59 მლნ.
EBT including unusual items
1,02 მლრდ.
76,89 მლნ.
865,54 მლნ.
1,14 მლრდ.
EBT excluding unusual items
881,21 მლნ.
310,73 მლნ.
905,90 მლნ.
1,31 მლრდ.
Income tax expense
46,89 მლნ.
-29,05 მლნ.
446,06 ათ.
-39,10 მლნ.
Effective tax rate
4,58%
-37,77%
0,05%
-3,42%
Other operating expenses
-17,06 მლნ.
38,39 მლნ.
10,48 მლნ.
10,49 მლნ.
Net income
978,96 მლნ.
134,74 მლნ.
866,00 მლნ.
1,18 მლრდ.
Net profit margin
190,48%
19,39%
168,45%
229,06%
Earnings per share
-
-
-
-
Interest and investment income
865,41 მლნ.
507,32 მლნ.
898,86 მლნ.
1,31 მლრდ.
Interest expense
-16,21 მლნ.
-15,71 მლნ.
-15,25 მლნ.
-6,62 მლნ.
Net interest expenses
849,20 მლნ.
491,61 მლნ.
883,61 მლნ.
1,31 მლრდ.
Depreciation and amortization charges
-
-
-
-
EBITDA
74,98 მლნ.
-121,80 მლნ.
70,71 მლნ.
44,84 მლნ.
Gain or loss from assets sale
127,66 ათ.
-1,32 მლნ.
-
4,80 მლნ.
AI content may include mistakes. Learn more
Google აპები